Safety of SABA Monotherapy in Asthma Management: a Systematic Review and Meta-analysis

INTRODUCTION: Short-acting β(2)-agonist (SABA) reliever overuse is common in asthma, despite availability of inhaled corticosteroid (ICS)-based maintenance therapies, and may be associated with increased risk of adverse events (AEs). This systematic literature review (SLR) and meta-analysis aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Sriprasart, Thitiwat, Waterer, Grant, Garcia, Gabriel, Rubin, Adalberto, Andrade, Marco Antonio Loustaunau, Roguska, Agnieszka, Phansalkar, Abhay, Fulmali, Sourabh, Martin, Amber, Mittal, Lalith, Aggarwal, Bhumika, Levy, Gur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859883/
https://www.ncbi.nlm.nih.gov/pubmed/36348141
http://dx.doi.org/10.1007/s12325-022-02356-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859883/
https://www.ncbi.nlm.nih.gov/pubmed/36348141
http://dx.doi.org/10.1007/s12325-022-02356-2

Ejemplares similares